Corporate News     15-Jun-17
Astrazeneca Pharma India receives Import and Market permission for Asthma drug
From Drug Controller General of India
Astrazeneca Pharma India has received Import and Market permission in Form 45 (Marketing Authorization) from the Drug Controller General of India for FDC of Budesonide 320 µg +Formoterol Fumarate Dihydrate 9 µg inhalation powder.

FDC of Budesonide 320 µg + Formoterol Fumarate Dihydrate 9 µg inhalation powder (Symbicort® Turbuhaler® 320/9 µg) is a product of AstraZeneca global and is indicated in the regular treatment of Asthma where use of combination of inhaled regular corticosteroid & long acting ß-agonist is appropriate and patients with moderate to severe COPD with frequent symptoms and a history of exacerbations

Previous News
  Astrazeneca Pharma India standalone net profit rises 60.84% in the September 2023 quarter
 ( Results - Announcements 10-Nov-23   07:33 )
  AstraZeneca Pharma Q4 PAT soars 129% YoY to Rs 39 cr
 ( Hot Pursuit - 28-May-24   11:45 )
  Volumes spurt at Astrazeneca Pharma India Ltd counter
 ( Hot Pursuit - 24-Sep-24   14:30 )
  AstraZeneca Pharma, Mankind Pharma partner to accelerate access to asthma medicine
 ( Hot Pursuit - 12-Mar-24   13:02 )
  Astrazeneca Pharma India standalone net profit declines 13.43% in the June 2020 quarter
 ( Results - Announcements 10-Aug-20   14:40 )
  AstraZeneca India gets govt nod for import & sale of cancer-treating drug Enhertu
 ( Hot Pursuit - 04-May-23   11:28 )
  Volumes jump at Astrazeneca Pharma India Ltd counter
 ( Hot Pursuit - 12-Sep-22   14:30 )
  Astrazeneca Pharma India AGM scheduled
 ( Corporate News - 12-Jul-19   16:40 )
  Astrazeneca Pharma India AGM scheduled
 ( Corporate News - 27-May-21   14:24 )
  Astrazeneca Pharma India to declare Quarterly Result
 ( Corporate News - 20-May-22   14:17 )
  Astrazeneca Pharma India reports standalone net loss of Rs 27.96 crore in the September 2014 quarter
 ( Results - Announcements 04-Nov-14   08:42 )
Other Stories
  ITD Cementation India wins order of Rs 1,937 cr
  03-Oct-24   10:35
  NIIT Learning Systems allots 1,666 equity shares under ESOP
  03-Oct-24   10:30
  Ashoka Metcast to discuss results
  03-Oct-24   10:29
  Emerald Finance to declare Quarterly Result
  03-Oct-24   10:29
  Rhetan TMT schedules board meeting
  03-Oct-24   10:29
  Shrenik to table results
  03-Oct-24   10:29
  Universal Arts to declare Quarterly Result
  03-Oct-24   10:28
  Three M Paper Boards to conduct board meeting
  03-Oct-24   10:28
  Arkade Developers to declare Quarterly Result
  03-Oct-24   10:28
  Worth Investment & Trading Company announces board meeting date
  03-Oct-24   10:28
Back Top